radRounds Radiology Network

Connecting Radiology | Enabling collaboration and professional development

(DIAGNOSTIC IMAGING) -- "Medical imaging takes key role in revolutionary new cancer protocol"

Imaging will play a pivotal role in a clinical trial that promises to change the way medical research is done, not only in oncology, but throughout medicine.

A multicenter trial, begun last week at the University of California, San Francisco and slated to expand to about 20 cancer centers in the U.S., will use medical images to assess patient response to experimental drugs being tested against breast cancer. The cancer trial will gauge how well drugs work in patients before their tumors have been surgically removed so that the effect of the drug can be quantified with medical imaging.

“By measuring tumor volume with imaging and validating that with pathological response, we will learn more about the use of images as a marker for drug effects,” said Dr. Janet Woodcock, director of the FDA Center for Drug Evaluation and Research.

Read more:

Views: 42


You need to be a member of radRounds Radiology Network to add comments!

Join radRounds Radiology Network

Sponsor Ad

© 2024   Created by radRounds Radiology Network.   Powered by

Badges  |  Report an Issue  |  Terms of Service